Report: Alex Rodriguez, Ryan Braun among players MLB seeks to suspend for Biogensis connection

124 Comments

Performance-enhancing drugs loomed large entering the baseball season, amid reports that dozens of players — many of them high-profile stars — could be suspended because of their reported involvement with a clinic that supplied PEDs.

That story just got bigger.

From ESPN.com investigative reporters T.J. Quinn, Pedro Gomez and Mike Fish:

Major League Baseball will seek to suspend about 20 players connected to the Miami-area clinic at the heart of an ongoing performance-enhancing drug scandal, including Alex Rodriguez and Ryan Braun, possibly within the next few weeks, “Outside the Lines” has learned. If the suspensions are upheld, the performance-enhancing drug scandal would be the largest in American sports history.

Tony Bosch, the former director of the Miami-based Biogenesis clinic, is “expected to begin meeting with officials — and naming names — within a week,” according to the ESPN.com report. A source familiar with the case confirmed to The Associated Press early Wednesday morning that Bosch has indeed agreed to talk to MLB about players linked to PEDs, and that Bosch’s information could lead to suspensions. The suspensions could be issued within two weeks, though there’s likely to be an appeals process and that may take a few months.

NBCSports.com reached both Major League Baseball and the Players’ Association on Tuesday night, but both declined to comment. Terry Fahn, Rodriguez’s publicist as of January, said to contact New York publicist Ron Berkowitz; Berkowitz declined to comment when reached by phone.

MORE: A closer look at the players facing potential suspensions

The commissioner’s office will be seeking 100-game punishments for Braun and A-Rod because they both committed two offenses — the initial doping and then lying to Major League Baseball officials. The typical punishment for first-time performance-enhancing drug offenders is a 50-game suspension.

Nationals left-hander Gio Gonzalez is not a candidate for suspension, according to Quinn, because Bosch is expected to confirm to the investigators that Gio only bought league-approved substances. Some of the other names that were found in the Biogenesis documents: Melky Cabrera, Bartolo Colon, Yasmani Grandal, Nelson Cruz, Francisco Cervelli, Jesus Montero, Jhonny Peralta, Cesar Puello, Fernando Martinez, Everth Cabrera, Fautino de los Santos and Jordan Norberto.

MORE: Why a mass suspension would be a mass fail

The Biogenesis news broke in late January, when it was reported by multiple outlets that Major League Baseball was investigating Bosch under the suspicion that his clinic represented “ground zero” for performance enhancing drugs in Florida, where a disproportionate number of major leaguers grew up, played amateur and college baseball or where they currently make their offseason homes. On January 29, the Miami New Times obtained and published a large portion of the Biogenesis clinic’s records which contained the names of several major leaguers accompanied in many cases by notations which suggested that the players were given performance enhancing drugs. The documents were not conclusive of any player’s use and, in some cases — like with Gio Gonzalez — no connection could be found between the player and any substances which are banned by Major League Baseball.

Immediately after the Miami New Times report came out all of the players involved either denied any involvement with Biogenesis whatsoever or denied that they obtained banned substances.  For example, Gonzalez claims that his father was a patient of Bosch’s. Ryan Braun claims that his attorneys used Bosch as a consultant in his successful 2012 appeal of his PED suspension. Despite the denials, the report and the documents set off a media firestorm which caused Major League Baseball to step up its investigation of the players named therein.

Report: Twins interested in Wade Miley

Getty Images
Leave a comment

Free agent left-hander Wade Miley is among several offseason targets for the Twins, according to a report from Darren Wolfson of KSTP. Miley’s $12 million option was declined by the Orioles back in November, and while he’s expected to attract another major league deal in 2018, he hasn’t exactly been highly sought after this offseason.

The 31-year-old lefty finished his second campaign with the Orioles in 2017, producing an 8-15 record in 32 starts and ranking second-to-last among all AL starters with a 5.61 ERA, 5.3 BB/9 and 8.1 SO/9 in 157 1/3 innings. Even taking Miley’s undeniable durability into account — he remained healthy for the bulk of the season and completed his sixth straight year with 30+ starts — his declining value and career-worst numbers may lower his price tag as the 2018 season approaches.

Wolfson notes that the Twins have engaged in “regular dialogue” with Miley’s agent this winter, but he’s far from the only starting pitcher they have their eye on. Right-handers Yu Darvish, Lance Lynn, Alex Cobb and Chris Tillman are still on their radar, among several others, and club owner Jim Pohlad said Saturday that he was “totally on board” with the idea of signing a big-name free agent like Darvish or another available starter. “There are some interesting names and some interesting opportunities there,” Pohlad told a crowd at TwinsFest. “I’m as intrigued by it as anybody and attracted to it as anybody.”